Τίτλος:
Altered Resistin Concentrations in Mid-trimester Amniotic Fluid of Fetuses With Trisomies 18 and 13: A window onto the pathophysiology of trisomies 18 and 13
Γλώσσες Τεκμηρίου:
Αγγλικά
Περίληψη:
Background/Aim: The study aimed to examine whether resistin is present in second trimester amniotic fluid from pregnancies with trisomy 18 and 13 and evaluate its concentration in comparison with euploid pregnancies. Patients and Methods: The study included 37 women who underwent amniocentesis. Eleven fetuses had trisomy 18, 3 had trisomy 13, while 23 had a normal karyotype. Results: Resistin was detected in all cases. The mean level of resistin in trisomy 18 was statistically significantly lower compared to euploid controls. Resistin levels in all abnormal cases were below its median concentration in euploid controls. ROC analysis showed very good prognostic value for both trisomies. Conclusion: Resistin is a constituent of mid-trimester amniotic fluid of pregnancies with trisomies 13 and 18, exhibiting lower levels than those in euploid fetuses. The reduced levels of resistin in amniotic fluid may be associated with early changes in metabolic pathways and immunoinflammatory responses. © 2019 International Institute of Anticancer Research. All Rights Reserved.
Συγγραφείς:
Vrachnis, N.
Dalakli, E.
Zygouris, D.
Vlachadis, N.
Salakos, N.
Botsis, D.
Kalantaridou, S.
Drakoulis, N.
Mastorakos, G.
Creatsas, G.
Deligeoroglou, E.
Iliodromiti, Z.
Περιοδικό:
In vivo (Athens, Greece)
Εκδότης:
International Institute of Anticancer Research
Λέξεις-κλειδιά:
resistin; resistin; RETN protein, human, adult; amniocentesis; amnion fluid; aneuploidy; Article; clinical article; female; fetus; gestational age; human; karyotype; male; maternal age; pathophysiology; second trimester pregnancy; trisomy 13; trisomy 18; amnion fluid; chemistry; chromosome 13; Edwards syndrome; genetics; pathology; pregnancy, Adult; Amniotic Fluid; Chromosomes, Human, Pair 13; Female; Gestational Age; Humans; Pregnancy; Pregnancy Trimester, Second; Resistin; Trisomy 18 Syndrome
DOI:
10.21873/invivo.11491
